Literature DB >> 72956

Aluminium hydroxide in bile-salt diarrhoea.

A Sali, W R Murray, C MacKay.   

Abstract

The treatment of choleraic diarrhoea remains a problem. Cholestyramine is effective but long-term treatment is often impracticable. In-vitro studies have shown that aluminium hydroxide has bile-acid-binding properties comparable with those of cholestyramine. The bile-acid-binding properties of aluminium hydroxide have now been investigated in vivo and applied to the treatment of patients with choleraic diarrhoea. Aluminium hydroxide increased the faecal bile-salt concentration of patients with a normal bowel habit whereas magnesium hydroxide had no effect. Eight patients with severe choleraic diarrhoea were treated with aluminium-hydroxide suspension: bowel motion became less frequent and daily faecal weight fell.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72956     DOI: 10.1016/s0140-6736(77)91884-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

Review 1.  Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

Authors:  P N Maton; M E Burton
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 2.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

3.  In vitro bile acid adsorption by bismuth subsalicylate and montmorillonite.

Authors:  S A Kocoshis; C N Ghent; J D Gryboski
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.